Robert Wasserman
Stock Analyst at Benchmark
(3.39)
# 960
Out of 5,131 analysts
123
Total ratings
50.47%
Success rate
3.45%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintains: Buy | $175 → $220 | $183.83 | +19.68% | 12 | Nov 7, 2025 | |
| PRLB Proto Labs | Maintains: Buy | $45 → $55 | $67.52 | -18.54% | 7 | Nov 3, 2025 | |
| ITGR Integer Holdings | Downgrades: Hold | n/a | $85.92 | - | 12 | Oct 24, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $75 → $90 | $79.44 | +13.29% | 10 | Sep 24, 2025 | |
| INTS Intensity Therapeutics | Maintains: Speculative Buy | $4 → $1.5 | $0.25 | +499.52% | 7 | Aug 20, 2025 | |
| TECH Bio-Techne | Reiterates: Buy | $75 | $59.93 | +25.15% | 7 | Jun 5, 2025 | |
| KMDA Kamada | Reiterates: Buy | $15 | $8.50 | +76.47% | 2 | May 15, 2025 | |
| OABI OmniAb | Reiterates: Buy | $6 | $1.70 | +252.94% | 9 | May 12, 2025 | |
| XOMA XOMA Royalty | Initiates: Buy | $35 | $24.01 | +45.77% | 1 | Apr 17, 2025 | |
| ABCL AbCellera Biologics | Reiterates: Hold | n/a | $3.10 | - | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $22.23 | +34.95% | 6 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $8 | $0.47 | +1,594.92% | 6 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $4.10 | +21.95% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $10.83 | +10.80% | 17 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.20 | - | 7 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $136.44 | - | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $4 | $3.47 | +15.27% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $100 | $2.22 | +4,404.50% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $75 | $3.61 | +1,977.56% | 2 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $212.58 | - | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $504.82 | +14.89% | 1 | Jul 16, 2021 |
Ligand Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $175 → $220
Current: $183.83
Upside: +19.68%
Proto Labs
Nov 3, 2025
Maintains: Buy
Price Target: $45 → $55
Current: $67.52
Upside: -18.54%
Integer Holdings
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $85.92
Upside: -
Halozyme Therapeutics
Sep 24, 2025
Maintains: Buy
Price Target: $75 → $90
Current: $79.44
Upside: +13.29%
Intensity Therapeutics
Aug 20, 2025
Maintains: Speculative Buy
Price Target: $4 → $1.5
Current: $0.25
Upside: +499.52%
Bio-Techne
Jun 5, 2025
Reiterates: Buy
Price Target: $75
Current: $59.93
Upside: +25.15%
Kamada
May 15, 2025
Reiterates: Buy
Price Target: $15
Current: $8.50
Upside: +76.47%
OmniAb
May 12, 2025
Reiterates: Buy
Price Target: $6
Current: $1.70
Upside: +252.94%
XOMA Royalty
Apr 17, 2025
Initiates: Buy
Price Target: $35
Current: $24.01
Upside: +45.77%
AbCellera Biologics
Mar 3, 2025
Reiterates: Hold
Price Target: n/a
Current: $3.10
Upside: -
Dec 19, 2024
Reiterates: Buy
Price Target: $30
Current: $22.23
Upside: +34.95%
Nov 19, 2024
Reiterates: Speculative Buy
Price Target: $8
Current: $0.47
Upside: +1,594.92%
Nov 12, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $4.10
Upside: +21.95%
Nov 7, 2024
Maintains: Buy
Price Target: $8 → $12
Current: $10.83
Upside: +10.80%
Nov 4, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.20
Upside: -
Aug 5, 2024
Reiterates: Hold
Price Target: n/a
Current: $136.44
Upside: -
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $3.47
Upside: +15.27%
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $100
Current: $2.22
Upside: +4,404.50%
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $3.61
Upside: +1,977.56%
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $212.58
Upside: -
Jul 16, 2021
Initiates: Buy
Price Target: $580
Current: $504.82
Upside: +14.89%